Welcome to AptAvian, Inc.!
We are a leading-edge biotechnology company committed to applying our innovative Aptagenic™ research and development to improving human health and well-being. Our team of experts uses aptamers—single-strand DNA and RNA molecules with selective binding properties—to discover and develop detection and therapeutic capabilities needed to address the expanding threat of diseases worldwide, collectively considered a pandemicine by health experts.
Explore our website to learn more about our company and its mission, values, and breakthrough technologies to prevent harm and loss from growing worldwide biological threats.
AptAvian lab opening celebration
Lancaster Farming article on AptAvian, Inc.
"Startup Company AptAvian, Inc. Works to Develop Avian Influenza Monitoring and Treatment"
Copyright © 2024 AptAvian™ - All Rights Reserved.
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.